{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:57:05Z","timestamp":1790816225779,"version":"4.1.0"},"reference-count":154,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5RO1DK125513)"],"award-info":[{"award-number":["5RO1DK125513)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Lipodystrophy syndromes are a heterogeneous group of rare genetic or acquired disorders characterized by generalized or partial loss of adipose tissue. LMNA-related lipodystrophy syndromes are classified based on the severity and distribution of adipose tissue loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We aimed to annotate all clinical and metabolic features of patients with lipodystrophy syndromes carrying pathogenic LMNA variants and assess potential genotype-phenotype relationships.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed and analyzed all our cases (n = 115) and all published cases (n = 379) curated from 94 studies in the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 494 patients. The most common variants in our study, R482Q and R482W, were associated with similar metabolic characteristics and complications though those with the R482W variant were younger (aged 33 [24] years vs 44 [25] years; P &amp;lt; .001), had an earlier diabetes diagnosis (aged 27 [18] vs 40 [17] years; P &amp;lt; .001) and had lower body mass index levels (24 [5] vs 25 [4]; P = .037). Dyslipidemia was the earliest biochemical evidence described in 83% of all patients at a median age of 26 (10) years, while diabetes was reported in 61% of cases. Among 39 patients with an episode of acute pancreatitis, the median age at acute pancreatitis diagnosis was 20 (17) years. Patients who were reported to have diabetes had 3.2 times, while those with hypertriglyceridemia had 12.0 times, the odds of having pancreatitis compared to those who did not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study reports the largest number of patients with LMNA-related lipodystrophy syndromes to date. Our report helps to quantify the prevalence of the known and rare complications associated with different phenotypes and serves as a comprehensive catalog of all known cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgad606","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T09:36:07Z","timestamp":1697189767000},"page":"e1204-e1224","source":"Crossref","is-referenced-by-count":26,"title":["Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3135-9617","authenticated-orcid":false,"given":"Ozge","family":"Besci","sequence":"first","affiliation":[{"name":"Division of Metabolism, Endocrinology & Diabetes, University of Michigan , Ann Arbor, MI 48109 , USA"},{"name":"Division of Pediatric Endocrinology, Dokuz Eylul University , Izmir 35340 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1350-1125","authenticated-orcid":false,"given":"Maria Christina","family":"Foss de Freitas","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology & Diabetes, University of Michigan , Ann Arbor, MI 48109 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2438-3141","authenticated-orcid":false,"given":"Nat\u00e1lia Rossin","family":"Guidorizzi","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, University of S\u00e3o Paulo, Ribeir\u00e3o Preto , S\u00e3o Paulo 05508 , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1112-7640","authenticated-orcid":false,"given":"Merve Celik","family":"Guler","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology & Diabetes, University of Michigan , Ann Arbor, MI 48109 , USA"},{"name":"Division of Internal Medicine, Dokuz Eylul University , Izmir 35340 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9609-6286","authenticated-orcid":false,"given":"Donatella","family":"Gilio","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology & Diabetes, University of Michigan , Ann Arbor, MI 48109 , USA"},{"name":"Department of Clinical and Translational Sciences, University of Pisa , Pisa 56126 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4289-0614","authenticated-orcid":false,"given":"Jessica N","family":"Maung","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan , Ann Arbor, MI 48105 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7123-0418","authenticated-orcid":false,"given":"Rebecca L","family":"Schill","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan , Ann Arbor, MI 48105 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5458-0155","authenticated-orcid":false,"given":"Keegan S","family":"Hoose","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan , Ann Arbor, MI 48105 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9814-3645","authenticated-orcid":false,"given":"Bonje N","family":"Obua","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan , Ann Arbor, MI 48105 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4666-715X","authenticated-orcid":false,"given":"Anabela D","family":"Gomes","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology & Diabetes, University of Michigan , Ann Arbor, MI 48109 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6801-8499","authenticated-orcid":false,"given":"Ilg\u0131n","family":"Y\u0131ld\u0131r\u0131m \u015eim\u015fir","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Ege University , Izmir 35100 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8334-2422","authenticated-orcid":false,"given":"Korcan","family":"Demir","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Dokuz Eylul University , Izmir 35340 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8634-4845","authenticated-orcid":false,"given":"Baris","family":"Akinci","sequence":"additional","affiliation":[{"name":"DEPARK, Dokuz Eylul University & Izmir Biomedicine and Genome Center , Izmir , Turkey"},{"name":"Izmir Biomedicine and Genome Center , Izmir 35340 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6907-7960","authenticated-orcid":false,"given":"Ormond A","family":"MacDougald","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology & Diabetes, University of Michigan , Ann Arbor, MI 48109 , USA"},{"name":"Department of Molecular & Integrative Physiology, University of Michigan , Ann Arbor, MI 48105 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9171-1144","authenticated-orcid":false,"given":"Elif A","family":"Oral","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology & Diabetes, University of Michigan , Ann Arbor, MI 48109 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"issue":"12","key":"2024022001144061400_dgad606-B1","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024022001144061400_dgad606-B2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/db19-0447","article-title":"Clinical and molecular prevalence of lipodystrophy in an unascertained large clinical care cohort","volume":"69","author":"Gonzaga-Jauregui","year":"2019","journal-title":"Diabetes"},{"issue":"11","key":"2024022001144061400_dgad606-B3","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Clinical review#: lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024022001144061400_dgad606-B4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/cells12050725","article-title":"Clinical spectrum of LMNA-associated type 2 familial partial lipodystrophy: a systematic review","volume":"12","author":"Fernandez-Pombo","year":"2023","journal-title":"Cells"},{"issue":"8","key":"2024022001144061400_dgad606-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0289-0","article-title":"Altered adipocyte differentiation and unbalanced autophagy in type 2 familial partial lipodystrophy: an in vitro and in vivo study of adipose tissue browning","volume":"51","author":"Pellegrini","year":"2019","journal-title":"Exp Mol Med"},{"issue":"12","key":"2024022001144061400_dgad606-B6","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1210\/jc.2009-0472","article-title":"Atypical progeroid syndrome due to heterozygous missense LMNA mutations","volume":"94","author":"Garg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024022001144061400_dgad606-B7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0002-9343(02)01070-7","article-title":"Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A\/C gene","volume":"112","author":"Garg","year":"2002","journal-title":"Am J Med"},{"issue":"9","key":"2024022001144061400_dgad606-B8","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1210\/jc.2004-2560","article-title":"A novel homozygous Ala529Val LMNA mutation in turkish patients with mandibuloacral dysplasia","volume":"90","author":"Garg","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2024022001144061400_dgad606-B9","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1173514","article-title":"Overview of cellular homeostasis-associated nuclear envelope lamins and associated input signals","volume":"11","author":"Kim","year":"2023","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2024022001144061400_dgad606-B10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41525-021-00266-w","article-title":"Lamin A\/C missense variants: from discovery to functional validation","volume":"6","author":"Lazarte","year":"2021","journal-title":"NPJ Genom Med"},{"issue":"1","key":"2024022001144061400_dgad606-B11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrm3488","article-title":"The nuclear lamins: flexibility in function","volume":"14","author":"Burke","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2024022001144061400_dgad606-B12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fendo.2018.00458","article-title":"Homozygous and heterozygous nuclear lamin A p.R582C mutation: different lipodystrophic phenotypes in the same kindred","volume":"9","author":"Montenegro","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2024022001144061400_dgad606-B13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/cen.13311","article-title":"Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort","volume":"86","author":"Ajluni","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2024022001144061400_dgad606-B14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cmet.2013.03.008","article-title":"Mechanisms and metabolic implications of regional differences among fat depots","volume":"17","author":"Tchkonia","year":"2013","journal-title":"Cell Metab"},{"issue":"9","key":"2024022001144061400_dgad606-B15","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/ATVBAHA.113.301933","article-title":"Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction","volume":"33","author":"Bidault","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2024022001144061400_dgad606-B16","first-page":"7","article-title":"Overlapping syndromes in laminopathies: a meta-analysis of the reported literature","volume":"32","author":"Carboni","year":"2013","journal-title":"Acta Myol"},{"issue":"1","key":"2024022001144061400_dgad606-B17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/BST0380257","article-title":"Genotype\u2013phenotype correlations in laminopathies: how does fate translate?","volume":"38","author":"Scharner","year":"2010","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"2024022001144061400_dgad606-B18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/cells12050783","article-title":"Epigenetics in LMNA-related cardiomyopathy","volume":"12","author":"Wang","year":"2023","journal-title":"Cells"},{"issue":"4","key":"2024022001144061400_dgad606-B19","first-page":"530","article-title":"Clinical profile, arrhythmias, and adverse cardiac outcomes in emery-dreifuss muscular dystrophies: a systematic review of the literature","volume":"11","author":"Valenti","year":"2022","journal-title":"Biology (Basel)"},{"key":"2024022001144061400_dgad606-B20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.metabol.2017.04.010","article-title":"Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy","volume":"72","author":"Akinci","year":"2017","journal-title":"Metab Clin Exp"},{"issue":"8","key":"2024022001144061400_dgad606-B21","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"2024022001144061400_dgad606-B22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ng0398-292","article-title":"Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21\u201322","volume":"18","author":"Peters","year":"1998","journal-title":"Nat Genet"},{"issue":"4","key":"2024022001144061400_dgad606-B23","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/302836","article-title":"Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A\/C","volume":"66","author":"Speckman","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2024022001144061400_dgad606-B24","first-page":"170","article-title":"Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety)1","volume":"84","author":"Garg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024022001144061400_dgad606-B25","first-page":"3431","article-title":"Heterogeneity of nuclear lamin a mutations in dunnigan-type familial partial lipodystrophy*","volume":"85","author":"Hegele","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024022001144061400_dgad606-B26","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.2337\/diabetes.49.11.1958","article-title":"Lamin A\/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy","volume":"49","author":"Vigouroux","year":"2000","journal-title":"Diabetes"},{"issue":"1","key":"2024022001144061400_dgad606-B27","first-page":"59","article-title":"Phenotypic heterogeneity in patients with familial partial lipodystrophy (Dunnigan variety) related to the site of missense mutations in lamin A\/C gene1","volume":"86","author":"Garg","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024022001144061400_dgad606-B28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jc.2002-021506","article-title":"A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy","volume":"88","author":"Caux","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024022001144061400_dgad606-B29","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1210\/jcem.86.5.7500","article-title":"Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene","volume":"86","author":"Schmidt","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024022001144061400_dgad606-B30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2265.2007.02870.x","article-title":"Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism","volume":"67","author":"Vantyghem","year":"2007","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2024022001144061400_dgad606-B31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1399-0004.2007.00740.x","article-title":"Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660)","volume":"71","author":"Lanktree","year":"2007","journal-title":"Clin Genet"},{"issue":"6","key":"2024022001144061400_dgad606-B32","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ahj.2007.07.038","article-title":"High yield of LMNA mutations in patients with dilated cardiomyopathy and\/or conduction disease referred to cardiogenetics outpatient clinics","volume":"154","author":"van Tintelen","year":"2007","journal-title":"Am Heart J"},{"issue":"7","key":"2024022001144061400_dgad606-B33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1503\/cmaj.070135","article-title":"Obstructive sleep apnea in 2 women with familial partial lipodystrophy due to a heterozygous LMNA R482Q mutation","volume":"177","author":"Hegele","year":"2007","journal-title":"CMAJ"},{"issue":"1","key":"2024022001144061400_dgad606-B34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-2003-38388","article-title":"Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A\/C R482W mutation","volume":"35","author":"Ara\u00fajo-Vilar","year":"2003","journal-title":"Horm Metab Res"},{"issue":"11","key":"2024022001144061400_dgad606-B35","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1210\/jc.2003-031658","article-title":"Patients with familial partial lipodystrophy of the dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities","volume":"89","author":"Vantyghem","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024022001144061400_dgad606-B36","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00125-004-1360-4","article-title":"Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene","volume":"47","author":"Savage","year":"2004","journal-title":"Diabetologia"},{"issue":"10","key":"2024022001144061400_dgad606-B37","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1572-0241.2005.00234.x","article-title":"Hepatic steatosis in dunnigan-type familial partial lipodystrophy","volume":"100","author":"L\u00fcdtke","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"2024022001144061400_dgad606-B38","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/WNL.59.4.620","article-title":"Lamin A\/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy","volume":"59","author":"van der Kooi","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"2024022001144061400_dgad606-B39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2342-6-11","article-title":"Semi-automated segmentation and quantification of adipose tissue in calf and thigh by MRI: a preliminary study in patients with monogenic metabolic syndrome","volume":"6","author":"Al-Attar","year":"2006","journal-title":"BMC Med Imaging"},{"issue":"23","key":"2024022001144061400_dgad606-B40","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1002\/ajmg.a.32046","article-title":"The heterozygous LMNA mutation p.R471G causes a variable phenotype with features of two types of familial partial lipodystrophy","volume":"143A","author":"Muschke","year":"2007","journal-title":"Am J Med Genet A"},{"issue":"12","key":"2024022001144061400_dgad606-B41","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/jc.2007-0654","article-title":"New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome","volume":"92","author":"Decaudain","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024022001144061400_dgad606-B42","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.metabol.2006.11.010","article-title":"Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy","volume":"56","author":"Park","year":"2007","journal-title":"Metab Clin Exp"},{"issue":"1","key":"2024022001144061400_dgad606-B43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2265.2007.03146.x","article-title":"A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy","volume":"69","author":"Ara\u00fajo-Vilar","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2024022001144061400_dgad606-B44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1464-5491.2003.01034.x","article-title":"Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene","volume":"20","author":"Owen","year":"2003","journal-title":"Diabet Med"},{"issue":"6","key":"2024022001144061400_dgad606-B45","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1210\/jc.2007-2521","article-title":"Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy","volume":"93","author":"Vantyghem","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024022001144061400_dgad606-B46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/EJE-08-0272","article-title":"Monogenic polycystic ovary syndrome due to a mutation in the lamin A\/C gene is sensitive to thiazolidinediones but not to metformin","volume":"159","author":"Gambineri","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2024022001144061400_dgad606-B47","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.4158\/EP.14.9.1126","article-title":"Prevalence of reproductive abnormalities among women with familial partial lipodystrophy","volume":"14","author":"Joy","year":"2008","journal-title":"Endocr Pract"},{"issue":"1","key":"2024022001144061400_dgad606-B48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12020-008-9127-1","article-title":"A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A\/C (LMNA) mutations complicated by end-stage renal disease","volume":"35","author":"Imachi","year":"2009","journal-title":"Endocrine"},{"issue":"2","key":"2024022001144061400_dgad606-B49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/AOG.0b013e31819feaa9","article-title":"Lipodystrophy: an unusual diagnosis in a case of oligomenorrhea and hirsutism","volume":"114","author":"Keller","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2024022001144061400_dgad606-B50","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12020-009-9265-0","article-title":"LMNA Gene mutation search in Polish patients: new features of the heterozygous Arg482Gln mutation phenotype","volume":"36","author":"Klupa","year":"2009","journal-title":"Endocrine"},{"issue":"1","key":"2024022001144061400_dgad606-B51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1399-0004.2009.01350.x","article-title":"Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A\/C mutations","volume":"78","author":"Subramanyam","year":"2010","journal-title":"Clin Genet"},{"issue":"3","key":"2024022001144061400_dgad606-B52","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-12-0268","article-title":"Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations","volume":"167","author":"Mory","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2024022001144061400_dgad606-B53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1758-5996-4-40","article-title":"Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation","volume":"4","author":"Valerio","year":"2012","journal-title":"Diabetol Metab Syndr"},{"issue":"04","key":"2024022001144061400_dgad606-B54","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-0031-1301284","article-title":"Thiazolidinedione response in familial lipodystrophy patients with LMNA mutations: a case series","volume":"44","author":"Luedtke","year":"2012","journal-title":"Horm Metab Res"},{"issue":"4","key":"2024022001144061400_dgad606-B55","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5603\/EP.2013.0010","article-title":"Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene - case study of three women from one family","volume":"64","author":"Nabrdalik","year":"2013","journal-title":"Endokrynol Pol"},{"issue":"1\u20132","key":"2024022001144061400_dgad606-B56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000354716","article-title":"Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA","volume":"124","author":"Thong","year":"2013","journal-title":"Nephron Clin Pract"},{"issue":"10","key":"2024022001144061400_dgad606-B57","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/dme.13061","article-title":"Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -\u03b3 (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 lamin A\/C (LMNA) mutations","volume":"33","author":"Demir","year":"2016","journal-title":"Diabet Med"},{"key":"2024022001144061400_dgad606-B58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2015.12.012","article-title":"A case of familial partial lipodystrophy caused by a novel lamin A\/C (LMNA) mutation in exon 1 (D47N)","volume":"29","author":"Kutbay","year":"2016","journal-title":"Eur J Intern Med"},{"key":"2024022001144061400_dgad606-B59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12887-016-0581-2","article-title":"Fitting the pieces of the puzzle together: a case report of the Dunnigan-type of familial partial lipodystrophy in the adolescent girl","volume":"16","author":"Krawiec","year":"2016","journal-title":"BMC Pediatr"},{"issue":"5","key":"2024022001144061400_dgad606-B60","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jcjd.2015.12.007","article-title":"A case of familial partial lipodystrophy: from clinical phenotype to genetics","volume":"40","author":"Vouillarmet","year":"2016","journal-title":"Can J Diabetes"},{"issue":"6","key":"2024022001144061400_dgad606-B61","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jacl.2016.08.012","article-title":"Familial partial lipodystrophy presenting as metabolic syndrome","volume":"10","author":"Chan","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"12","key":"2024022001144061400_dgad606-B62","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/ajmg.a.32331","article-title":"Extreme phenotypic diversity and nonpenetrance in families with the LMNA gene mutation R644C","volume":"146A","author":"Rankin","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"7","key":"2024022001144061400_dgad606-B63","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3390\/jcm10071497","article-title":"Variable expressivity and allelic heterogeneity in type 2 familial partial lipodystrophy: the p.(Thr528Met) LMNA variant","volume":"10","author":"Ara\u00fajo-Vilar","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"2024022001144061400_dgad606-B64","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000320166","article-title":"A novel LMNA mutation causes altered nuclear morphology and symptoms of familial partial lipodystrophy (Dunnigan variety) with progeroid features","volume":"1","author":"Saha","year":"2010","journal-title":"Mol Syndromol"},{"issue":"1","key":"2024022001144061400_dgad606-B65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40842-020-00100-9","article-title":"Homozygous LMNA p.R582H pathogenic variant reveals increasing effect on the severity of fat loss in lipodystrophy","volume":"6","author":"Soyaltin","year":"2020","journal-title":"Clin Diabetes Endocrinol"},{"issue":"4","key":"2024022001144061400_dgad606-B66","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11605-016-3300-2","article-title":"Successful treatment of an unusual case of FPLD2: the role of roux-en-Y gastric bypass\u2014case report and literature review","volume":"21","author":"Grundfest-Broniatowski","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"2024022001144061400_dgad606-B67","first-page":"17-0049","article-title":"Familial partial lipodystrophy and proteinuric renal disease due to a missense c.1045C&gt;T LMNA mutation","volume":"2017","author":"Fountas","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"9","key":"2024022001144061400_dgad606-B68","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1515\/jpem-2022-0208","article-title":". Severe loss of adipose tissue in a Vietnamese lipodystrophy patient caused by LMNA p.G465D mutation: a first clinical characterization and two-year follow-up","volume":"35","author":"Vu","year":"2022","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"2024022001144061400_dgad606-B69","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0028-3843(14)60044-X","article-title":"Familial partial lipodystrophy associated with the heterozygous LMNA mutation 1445G&gt;A (Arg482Gln) in a Polish family","volume":"44","author":"Drac","year":"2010","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"2024022001144061400_dgad606-B70","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13104-015-1065-4","article-title":"Familial partial lipodystrophy, Dunnigan variety - challenges for patient care during pregnancy: a case report","volume":"8","author":"Belo","year":"2015","journal-title":"BMC Res Notes"},{"issue":"2","key":"2024022001144061400_dgad606-B71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.diabet.2009.01.001","article-title":"Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: a case report","volume":"35","author":"Collet-Gaudillat","year":"2009","journal-title":"Diabetes Metab"},{"issue":"5","key":"2024022001144061400_dgad606-B72","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1055\/s-0028-1128138","article-title":"Comparison of phenotypes in male and female individuals of a new family with Dunnigan type of familial partial lipodystrophy due to a lamin A\/C R482W mutation","volume":"41","author":"Laudes","year":"2009","journal-title":"Horm Metab Res"},{"issue":"3","key":"2024022001144061400_dgad606-B73","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.diabet.2013.12.008","article-title":"LMNA Gene mutation as a model of cardiometabolic dysfunction: from genetic analysis to treatment response","volume":"40","author":"Chirico","year":"2014","journal-title":"Diabetes Metab"},{"issue":"3","key":"2024022001144061400_dgad606-B74","article-title":"An uncommon association of familial partial lipodystrophy, dilated cardiomyopathy, and conduction system disease","volume":"4","author":"Panikkath","year":"2016","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"6","key":"2024022001144061400_dgad606-B75","doi-asserted-by":"crossref","first-page":"550","DOI":"10.5603\/EP.2015.0067","article-title":"Familial partial lipodystrophy as differential diagnosis of polycystic ovary syndrome","volume":"66","author":"Lewandowski","year":"2015","journal-title":"Endokrynol Pol"},{"issue":"1","key":"2024022001144061400_dgad606-B76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MCD.0000000000000355","article-title":"Novel clinical features and pleiotropic effect in three unrelated patients with LMNA variant","volume":"30","author":"Turkyilmaz","year":"2021","journal-title":"Clin Dysmorphol"},{"issue":"8","key":"2024022001144061400_dgad606-B77","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1590\/S0004-27302008000800008","article-title":"Atypical generalized lipoatrophy and severe insulin resistance due to a heterozygous LMNA p.T10I mutation","volume":"52","author":"Mory","year":"2008","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"7","key":"2024022001144061400_dgad606-B78","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1515\/jpem-2019-0107","article-title":"Short stature in a boy with atypical progeria syndrome due to LMNA c.433G&gt;A [p.(Glu145Lys)]: apparent growth hormone deficiency but poor response to growth hormone therapy","volume":"32","author":"Toni","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"2024022001144061400_dgad606-B79","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/mus.21443","article-title":"Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement","volume":"41","author":"Carboni","year":"2010","journal-title":"Muscle Nerve"},{"issue":"9","key":"2024022001144061400_dgad606-B80","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/ajmg.a.38341","article-title":"Juvenile-onset generalized lipodystrophy due to a novel heterozygous missense LMNA mutation affecting lamin C","volume":"173","author":"Patni","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"6","key":"2024022001144061400_dgad606-B81","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1210\/jc.2002-021575","article-title":"Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy","volume":"88","author":"Simha","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024022001144061400_dgad606-B82","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1210\/jc.2007-0116","article-title":"Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype","volume":"92","author":"Lombardi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024022001144061400_dgad606-B83","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/ajmg.a.33005","article-title":"Mandibuloacral dysplasia type A in childhood","volume":"149a","author":"Garavelli","year":"2009","journal-title":"Am J Med Genet A"},{"issue":"21","key":"2024022001144061400_dgad606-B84","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/ajmg.a.31983","article-title":"Mandibuloacral dysplasia and a novel LMNA mutation in a woman with severe progressive skeletal changes","volume":"143a","author":"Kosho","year":"2007","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2024022001144061400_dgad606-B85","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/1471-2431-14-256","article-title":"Mandibuloacral dysplasia type A-associated progeria caused by homozygous LMNA mutation in a family from southern China","volume":"14","author":"Luo","year":"2014","journal-title":"BMC Pediatr"},{"issue":"11","key":"2024022001144061400_dgad606-B86","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jmg.40.11.854","article-title":"Mandibuloacral dysplasia caused by homozygosity for the R527H mutation in lamin A\/C","volume":"40","author":"Shen","year":"2003","journal-title":"J Med Genet"},{"issue":"10","key":"2024022001144061400_dgad606-B87","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/genes12101508","article-title":"Two decades after mandibuloacral dysplasia discovery: additional cases and comprehensive view of disease characteristics","volume":"12","author":"J\u00e9ru","year":"2021","journal-title":"Genes (Basel)"},{"issue":"12","key":"2024022001144061400_dgad606-B88","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1210\/jc.2008-0123","article-title":"Severe mandibuloacral dysplasia-associated lipodystrophy and progeria in a young girl with a novel homozygous Arg527Cys LMNA mutation","volume":"93","author":"Agarwal","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024022001144061400_dgad606-B89","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ajmg.a.32259","article-title":"Association of homozygous LMNA mutation R471C with new phenotype: mandibuloacral dysplasia, progeria, and rigid spine muscular dystrophy","volume":"146a","author":"Zirn","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"12","key":"2024022001144061400_dgad606-B90","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1210\/jc.2005-0939","article-title":"Phenotypic heterogeneity in body fat distribution in patients with atypical Werner's Syndrome due to heterozygous Arg133Leu lamin A\/C mutation","volume":"90","author":"Jacob","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024022001144061400_dgad606-B91","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/jc.2005-1297","article-title":"A homozygous mutation in the lamin A\/C gene associated with a novel syndrome of arthropathy, tendinous calcinosis, and progeroid features","volume":"91","author":"Van Esch","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024022001144061400_dgad606-B92","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.4158\/ACCR-2019-0366","article-title":"UNUSUAL PRESENTATIONS OF LMNA-ASSOCIATED LIPODYSTROPHY WITH COMPLEX PHENOTYPES AND GENERALIZED FAT LOSS: WHEN THE GENETIC DIAGNOSIS UNCOVERS NOVEL FEATURES","volume":"6","author":"de Andrade","year":"2020","journal-title":"AACE Clin Case Rep"},{"issue":"6","key":"2024022001144061400_dgad606-B93","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/pde.13917","article-title":"Diffuse, mottled hyperpigmentation and mutations in LMNA gene in a 5-year-old boy, his mother, and his grandmother: atypical progeroid syndrome","volume":"36","author":"Schultz","year":"2019","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"2024022001144061400_dgad606-B94","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ejhg.2012.77","article-title":"A novel homozygous p.Arg527Leu LMNA mutation in two unrelated Egyptian families causes overlapping mandibuloacral dysplasia and progeria syndrome","volume":"20","author":"Al-Haggar","year":"2012","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"2024022001144061400_dgad606-B95","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gene.2014.05.042","article-title":"P.Pro4Arg mutation in LMNA gene: a new atypical progeria phenotype without metabolism abnormalities","volume":"546","author":"Guo","year":"2014","journal-title":"Gene"},{"issue":"9","key":"2024022001144061400_dgad606-B96","doi-asserted-by":"crossref","first-page":"1166.e1129","DOI":"10.1016\/j.cjca.2015.11.011","article-title":"A case of novel lamin A\/C mutation manifesting as atypical progeroid syndrome and cardiomyopathy","volume":"32","author":"Guo","year":"2016","journal-title":"Can J Cardiol"},{"issue":"11","key":"2024022001144061400_dgad606-B97","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1507\/endocrj.EJ19-0014","article-title":"Diabetes mellitus coexisted with progeria: a case report of atypical werner syndrome with novel LMNA mutations and literature review","volume":"66","author":"He","year":"2019","journal-title":"Endocr J"},{"key":"2024022001144061400_dgad606-B98","article-title":"Atypical progeroid syndrome (p.E262K LMNA mutation): a rare cause of short stature and osteoporosis","volume":"2021","author":"Yukina","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"4","key":"2024022001144061400_dgad606-B99","doi-asserted-by":"crossref","first-page":"e00375","DOI":"10.14309\/crj.0000000000000375","article-title":"Hepatic steatosis resulting from LMNA-associated familial lipodystrophy","volume":"7","author":"Mahdi","year":"2020","journal-title":"ACG Case Rep J"},{"issue":"10","key":"2024022001144061400_dgad606-B100","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa104","article-title":"Multisystem progeroid syndrome with lipodystrophy, cardiomyopathy, and nephropathy due to an LMNA p.R349W variant","volume":"4","author":"Hussain","year":"2020","journal-title":"J Endocr Soc"},{"issue":"10","key":"2024022001144061400_dgad606-B101","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa108","article-title":"Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation","volume":"4","author":"Magno","year":"2020","journal-title":"J Endocr Soc"},{"issue":"9","key":"2024022001144061400_dgad606-B102","article-title":"The clinical characteristics and potential molecular mechanism of LMNA mutation-related lipodystrophy","volume":"7","author":"Xiao","year":"2023","journal-title":"Adv Biol (Weinh)"},{"key":"2024022001144061400_dgad606-B103","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.1032653","article-title":"Case report: focal segmental glomerulosclerosis in a pediatric atypical progeroid syndrome","volume":"10","author":"Jang","year":"2022","journal-title":"Front Pediatr"},{"issue":"9","key":"2024022001144061400_dgad606-B104","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/jdi.13827","article-title":"Severe aortic stenosis during leptin replacement therapy in a patient with generalized lipodystrophy-associated progeroid syndrome due to an LMNA variant: A case report","volume":"13","author":"Sasako","year":"2022","journal-title":"J Diabetes Investig"},{"key":"2024022001144061400_dgad606-B105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jdcr.2021.08.011","article-title":"Mandibuloacral dysplasia in a young Vietnamese girl caused by homozygous missense variant c.1579C&gt;T in the LMNA gene with progeria and severe skin lesions","volume":"16","author":"Doanh","year":"2021","journal-title":"JAAD Case Rep"},{"key":"2024022001144061400_dgad606-B106","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.675096","article-title":"Case report: an atypical form of familial partial lipodystrophy type 2 due to mutation in the rod domain of lamin A\/C","volume":"12","author":"Cecchetti","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2024022001144061400_dgad606-B107","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1507\/endocrj.EJ19-0226","article-title":"A case of generalized lipodystrophy-associated progeroid syndrome treated by leptin replacement with short and long-term monitoring of the metabolic and endocrine profiles","volume":"67","author":"Fukaishi","year":"2020","journal-title":"Endocr J"},{"issue":"1","key":"2024022001144061400_dgad606-B108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.aace.2021.06.005","article-title":"Rare diagnosis of familial partial lipodystrophy in a patient with life-threatening pancreatitis due to hypertriglyceridemia","volume":"8","author":"Akamnonu","year":"2022","journal-title":"AACE Clin Case Rep"},{"key":"2024022001144061400_dgad606-B109","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fendo.2018.00433","article-title":"Cerebral haemorrhage in a young patient with atypical werner syndrome due to mutations in LMNA","volume":"9","author":"Yanhua","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2024022001144061400_dgad606-B110","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/cen.14426","article-title":"Cardiac phenotype in familial partial lipodystrophy","volume":"94","author":"Eldin","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024022001144061400_dgad606-B111","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40842-021-00132-9","article-title":"Risk factors for diabetic foot ulcers in metreleptin na\u00efve patients with lipodystrophy","volume":"7","author":"Saydam","year":"2021","journal-title":"Clin Diabetes Endocrinol"},{"issue":"7","key":"2024022001144061400_dgad606-B112","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.medj.2021.04.001","article-title":"Metreleptin therapy for nonalcoholic steatohepatitis: open-label therapy interventions in two different clinical settings","volume":"2","author":"Akinci","year":"2021","journal-title":"Med"},{"issue":"6","key":"2024022001144061400_dgad606-B113","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacl.2022.08.008","article-title":"Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: results of the BROADEN study: volanesorsen in FPLD; the BROADEN study","volume":"16","author":"Oral","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"10","key":"2024022001144061400_dgad606-B114","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.2337\/dc18-0978","article-title":"\u201cFat shadows\u201d from DXA for the qualitative assessment of lipodystrophy: when a picture is worth a thousand numbers","volume":"41","author":"Meral","year":"2018","journal-title":"Diabetes Care"},{"issue":"3","key":"2024022001144061400_dgad606-B115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12020-018-1589-1","article-title":"Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy","volume":"60","author":"Brown","year":"2018","journal-title":"Endocrine"},{"issue":"1","key":"2024022001144061400_dgad606-B116","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/cen.13732","article-title":"Renal complications of lipodystrophy: a closer look at the natural history of kidney disease","volume":"89","author":"Akinci","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2024022001144061400_dgad606-B117","first-page":"659","article-title":"Efficacy and safety of metreleptin in patients with partial lipodystrophy: lessons from an expanded access program","volume":"7","author":"Ajluni","year":"2016","journal-title":"J Diabetes Metab"},{"issue":"1","key":"2024022001144061400_dgad606-B118","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12944-021-01589-4","article-title":"Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study","volume":"20","author":"Foss-Freitas","year":"2021","journal-title":"Lipids Health Dis"},{"issue":"7","key":"2024022001144061400_dgad606-B119","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1210\/jc.2005-2746","article-title":"A LMNA splicing mutation in two sisters with severe Dunnigan-type familial partial lipodystrophy type 2","volume":"91","author":"Morel","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024022001144061400_dgad606-B120","doi-asserted-by":"crossref","first-page":"E856","DOI":"10.1210\/jc.2010-2234","article-title":"A homozygous mutation of prelamin-A preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A","volume":"96","author":"Le Dour","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024022001144061400_dgad606-B121","first-page":"e28629","article-title":"Hutchinson-Gilford progeria syndrome: a literature review","volume":"14","author":"Lamis","year":"2022","journal-title":"Cureus"},{"issue":"6937","key":"2024022001144061400_dgad606-B122","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson\u2013Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"issue":"Supplement_1","key":"2024022001144061400_dgad606-B123","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2022","journal-title":"Diabetes Care"},{"issue":"8","key":"2024022001144061400_dgad606-B124","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics\u20142023 update: a report from the American heart association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"issue":"Supplement_1","key":"2024022001144061400_dgad606-B125","first-page":"S175","article-title":"11. Chronic kidney disease and risk management: standards of medical care in diabetes\u20142022","volume":"45","author":"Committee ADAPP","year":"2021","journal-title":"Diabetes Care"},{"issue":"9","key":"2024022001144061400_dgad606-B126","doi-asserted-by":"crossref","first-page":"e7038","DOI":"10.1371\/journal.pone.0007038","article-title":"Dual energy X-ray absorptiometry body composition reference values from NHANES","volume":"4","author":"Kelly","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"2024022001144061400_dgad606-B127","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/oby.23049","article-title":"The metabolic equivalent BMI in patients with familial partial lipodystrophy (FPLD) compared with those with severe obesity","volume":"29","author":"Koo","year":"2021","journal-title":"Obesity (Silver Spring)"},{"key":"2024022001144061400_dgad606-B128","author":"Besci","year":"2023"},{"issue":"1","key":"2024022001144061400_dgad606-B129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-0004.2005.00447.x","article-title":"LMNA Mutation position predicts organ system involvement in laminopathies","volume":"68","author":"Hegele","year":"2005","journal-title":"Clin Genet"},{"issue":"4","key":"2024022001144061400_dgad606-B130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/EJE-21-0282","article-title":"A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies","volume":"185","author":"Treiber","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2024022001144061400_dgad606-B131","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac155","article-title":"Phenotypic differences among familial partial lipodystrophy due to LMNA or PPARG variants","volume":"6","author":"Vasandani","year":"2022","journal-title":"J Endocr Soc"},{"issue":"5","key":"2024022001144061400_dgad606-B132","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2337\/diacare.26.5.1350","article-title":"Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety","volume":"26","author":"Haque","year":"2003","journal-title":"Diabetes Care"},{"issue":"25","key":"2024022001144061400_dgad606-B133","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"2024022001144061400_dgad606-B134","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacl.2020.04.009","article-title":"The association between triglycerides and incident cardiovascular disease: what is \u201coptimal\u201d?","volume":"14","author":"Aberra","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"12","key":"2024022001144061400_dgad606-B135","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1001\/jamainternmed.2016.6875","article-title":"Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis","volume":"176","author":"Pedersen","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"2","key":"2024022001144061400_dgad606-B136","doi-asserted-by":"crossref","first-page":"101409","DOI":"10.1016\/j.diabet.2022.101409","article-title":"Lipoatrophic diabetes in familial partial lipodystrophy type 2: from insulin resistance to diabetes","volume":"49","author":"Treiber","year":"2023","journal-title":"Diabetes Metab"},{"key":"2024022001144061400_dgad606-B137","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.2147\/IJGM.S377463","article-title":"Prevalence and pattern of dyslipidemia and its associated factors among patients with type 2 diabetes mellitus in Jordan: a cross-sectional study","volume":"15","author":"Al Quran","year":"2022","journal-title":"Int J Gen Med"},{"issue":"12","key":"2024022001144061400_dgad606-B138","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1046\/j.1464-5491.2002.00796.x","article-title":"Post-mortem findings in familial partial lipodystrophy, Dunnigan variety","volume":"19","author":"Haque","year":"2002","journal-title":"Diabet Med"},{"issue":"5","key":"2024022001144061400_dgad606-B139","first-page":"1776","article-title":"Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety)","volume":"85","author":"Garg","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024022001144061400_dgad606-B140","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacl.2021.07.004","article-title":"Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2","volume":"15","author":"Lazarte","year":"2021","journal-title":"J Clin Lipidol"},{"issue":"6","key":"2024022001144061400_dgad606-B141","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1053\/j.gastro.2018.01.024","article-title":"Lamin A\/C maintains exocrine pancreas homeostasis by regulating stability of RB and activity of E2F","volume":"154","author":"Elenbaas","year":"2018","journal-title":"Gastroenterology"},{"issue":"7","key":"2024022001144061400_dgad606-B142","doi-asserted-by":"crossref","first-page":"9051","DOI":"10.1096\/fj.202000500R","article-title":"Genotype-phenotype analysis of LMNA-related diseases predicts phenotype-selective alterations in lamin phosphorylation","volume":"34","author":"Lin","year":"2020","journal-title":"FASEB J"},{"issue":"2","key":"2024022001144061400_dgad606-B143","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrendo.2014.185","article-title":"Biology of upper-body and lower-body adipose tissue\u2014link to whole-body phenotypes","volume":"11","author":"Karpe","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2024022001144061400_dgad606-B144","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/osp4.319","article-title":"Visceral fat does not contribute to metabolic disease in lipodystrophy","volume":"5","author":"Malandrino","year":"2019","journal-title":"Obes Sci Pract"},{"issue":"15","key":"2024022001144061400_dgad606-B145","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N Engl J Med"},{"issue":"9","key":"2024022001144061400_dgad606-B146","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.2337\/diabetes.51.9.2727","article-title":"Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy","volume":"51","author":"Colombo","year":"2002","journal-title":"Diabetes"},{"issue":"3","key":"2024022001144061400_dgad606-B147","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1210\/jc.2017-02078","article-title":"A novel generalized lipodystrophy-associated progeroid syndrome due to recurrent heterozygous LMNA p.T10I mutation","volume":"103","author":"Hussain","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024022001144061400_dgad606-B148","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1210\/jc.2018-02787","article-title":"Efficacy of metreleptin treatment in familial partial lipodystrophy due to PPARG vs LMNA pathogenic variants","volume":"104","author":"Sekizkardes","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024022001144061400_dgad606-B149","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophies","volume":"87","author":"Haque","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2024022001144061400_dgad606-B150","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S1098-3597(06)80039-6","article-title":"Adipose tissue dysfunction in obesity and lipodystrophy","volume":"8","author":"Garg","year":"2006","journal-title":"Clin Cornerstone"},{"issue":"1","key":"2024022001144061400_dgad606-B151","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13098-023-01055-4","article-title":"Familial partial lipodystrophy type 2 and obesity, two adipose tissue pathologies with different inflammatory profiles","volume":"15","author":"Treiber","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"2024022001144061400_dgad606-B152","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cyto.2016.04.015","article-title":"Serum concentrations of fibroblast growth factor 21 are elevated in patients with congenital or acquired lipodystrophy","volume":"83","author":"Miehle","year":"2016","journal-title":"Cytokine"},{"issue":"10","key":"2024022001144061400_dgad606-B153","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1172\/JCI129190","article-title":"What lipodystrophies teach us about the metabolic syndrome","volume":"129","author":"Mann","year":"2019","journal-title":"J Clin Invest"},{"issue":"9","key":"2024022001144061400_dgad606-B154","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.2337\/db20-1001","article-title":"Adipocyte-specific deletion of lamin A\/C largely models human familial partial lipodystrophy type 2","volume":"70","author":"Corsa","year":"2021","journal-title":"Diabetes"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad606\/53253786\/dgad606.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/3\/e1204\/56680854\/dgad606.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/3\/e1204\/56680854\/dgad606.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T20:19:17Z","timestamp":1708373957000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/3\/e1204\/7318161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":154,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,10,16]]},"published-print":{"date-parts":[[2024,2,20]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad606","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2023,10,16]]}}}